3E043VH
3E043VH — Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduce Human B-type Peptide in Central Vein, Perc
How 3E043VH is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 4Body partThe specific site
- 3ApproachHow the site was reached
- VDeviceWhat was left in place, if anything
- HQualifierA further distinction where one applies
Codes near 3E043VH
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E043GRIntroduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach
- 3E043HZIntroduction of Radioactive Substance into Central Vein, Percutaneous Approach
- 3E043KZIntroduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach
- 3E043NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach
- 3E043PZIntroduction of Platelet Inhibitor into Central Vein, Percutaneous Approach
- 3E043RZIntroduction of Antiarrhythmic into Central Vein, Percutaneous Approach
- 3E043TZIntroduction of Destructive Agent into Central Vein, Percutaneous Approach
- 3E043VGIntroduction of Insulin into Central Vein, Percutaneous Approach
- 3E043VHIntroduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach
- 3E043VJIntroduction of Other Hormone into Central Vein, Percutaneous Approach
- 3E043WKIntroduction of Immunostimulator into Central Vein, Percutaneous
- 3E043WLIntroduction of Immunosuppressive into Central Vein, Percutaneous
- 3E043XZIntroduction of Vasopressor into Central Vein, Percutaneous Approach
- 3E05002Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach
- 3E05003Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach
- 3E05005Introduction of Other Antineoplastic into Peripheral Artery, Open Approach
- 3E0500MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach